Category Archives: Press Releases

Firalis contribute to the Pacific CONSORTIUM through its proprietary targeted RNA sequencing tools FiMICS and BIOPRED to redefine heart failure with preserved ejection fraction (HFpEF)

  Major health stakeholders in France launch the PACIFIC Consortium to redefine heart failure with preserved ejection fraction (HFpEF) Paris (France) - January 21, 2019 - Sanofi, Servier, Medicen Paris-Region, BpiFrance, the “Secrétariat Général Pour l’Investissement”, “l’Assistance Publique– Hôpitaux de Paris”, Inserm, Bioserenity, Casis, Fealinx and Firalis announced the launch of the PACIFIC consortium (Physiopathology,…
Read more

Amoneta Diagnostics is launching a participative fundraising campaign to launch its first-ever blood diagnostic test for Alzheimer’s disease.

  Amoneta Diagnostics lance une campagne de financement participatif afin de réunir les fonds nécessaires au lancement commercial de son tout premier test IVD ADDIA. Un test de diagnostic sanguin pour la maladie d'Alzheimer.  Please see below French PR. France, Huningue, le 19 Novembre 2018 La maladie d’Alzheimer touche 47 millions de personnes à l’échelle…
Read more

Firalis S.A. and Celemics Inc. launch the FiMICS® panel.

Firalis S.A. and Celemics, Inc. announce an agreement for the commercialization of a unique proprietary long non-coding RNA (lncRNA) panel, FiMICS®.  The precise quantification of 3233 cardiac-enriched lncRNAs in peripheral blood samples would better characterize patients with diverse cardiac disorders and toxicities. France, Huningue, 19th, September 2018 Firalis S.A. (“Firalis”), a Huningue based developer and…
Read more

FIRALIS S.A. announces the launch of the Biopred panel

FIRALIS S.A. announces the launch of the Biopred panel, an innovative RUO product that profiles thousands of mRNAs associated with inflammatory autoimmune disorders via a pioneering targeted mRNA profiling technology without RNA extraction. France, Huningue, 23th May 2018 Firalis S.A (“Firalis”), a developer of biomarker-based products and provider of biomarker services announced the release of…
Read more